CVE-2023-22868: IBM Aspera Faspex cross-site scripting

Q: What is the vulnerability ID of this vulnerability?

The vulnerability ID of this vulnerability is CVE-2023-22868.

Q: What is the severity of CVE-2023-22868?

The severity of CVE-2023-22868 is classified as medium.

Q: How does the vulnerability in IBM Aspera Faspex 4.4.1 affect users?

The vulnerability in IBM Aspera Faspex 4.4.1 allows users to embed arbitrary JavaScript code in the Web UI, potentially leading to credentials disclosure within a trusted session.

Q: How can I fix the vulnerability in IBM Aspera Faspex 4.4.1?

To fix the vulnerability in IBM Aspera Faspex 4.4.1, you should apply the necessary patches or updates provided by IBM.

Q: Where can I find more information about CVE-2023-22868?

You can find more information about CVE-2023-22868 on the IBM X-Force ID page.

Published Feb 17, 2023

Updated

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Affected Software

4 affected components

IBM Aspera Faspex<=4.4.1

IBM Aspera Faspex=4.4.1-patch_level_1

Linux Linux Kernel

Microsoft Windows

Remediation

Patch Available

https://www.ibm.com/support/pages/node/6952319

Event History

Feb 17, 2023

CVE Published

via MITRE·04:01 PM

Data Sourced

via MITRE·04:01 PM

DescriptionSeverityWeakness

Nov 13, 2024

Data Sourced

via IBM·06:39 PM

DescriptionSeverityAffected Software

Parent advisories

This vulnerability appears in the following advisories.

IBM-6952319

Frequently Asked Questions

What is the vulnerability ID of this vulnerability?

The vulnerability ID of this vulnerability is CVE-2023-22868.

What is the severity of CVE-2023-22868?

The severity of CVE-2023-22868 is classified as medium.

How does the vulnerability in IBM Aspera Faspex 4.4.1 affect users?